• ACO/ARO/AIO-21 - Capecitabine-...
  • *Description*

*Result*: ACO/ARO/AIO-21 - Capecitabine-based chemoradiotherapy in combination with the IL-1 receptor antagonist anakinra for rectal cancer Patients: A phase I trial of the German rectal cancer study group

*Title*:
ACO/ARO/AIO-21 - Capecitabine-based chemoradiotherapy in combination with the IL-1 receptor antagonist anakinra for rectal cancer Patients: A phase I trial of the German rectal cancer study group / Maximilian Fleischmann, Markus Diefenhardt, Adele Mikheal Nicolas, Franz Rödel, Michael Ghadimi, Ralf-Dieter Hofheinz, Florian Greten, Claus Rödel, Emmanouil Fokas
*Author/editor-in-chief*:
Fleischmann, Maximilian (Verfasser) ; Diefenhardt, Markus (Verfasser) ; Nicolas, Adele Mikheal (Verfasser) ; Rödel, Franz (Verfasser); Ghadimi, Michael (Verfasser) ; Hofheinz, Ralf-Dieter (Verfasser) ; Greten, Florian (Verfasser) ; Rödel, Claus (Verfasser) ; Fokas, Emmanouil (Verfasser) 
*Published in*:
Clinical and Translational Radiation Oncology. - Amsterdam : Elsevier, 06.04.2022. - Seite 99-106. - 10.1016/j.ctro.2022.04.003. - ISSN 2405-6308. - Jahrgang 34
*Publication*:
Amsterdam : Elsevier, 06.04.2022
*Distribution*:
Frankfurt am Main : Universitätsbibliothek Johann Christian Senckenberg
*Physical description scale*:
1 Online-Ressource (8 Seiten)
*Format*:
*eBook*
*Language*:
*eng*
*DOI*:
10.1016/j.ctro.2022.04.003
*oa_rights*:
Open Access
CC BY 4.0

*Additional information*

*Additional functions*